NASDAQ Grants Eightco’s Request for Continued Listing on The Nasdaq Capital Market Continued listing is subject to meeting certain conditions by August 23, 2024 including maintaining a minimum bid price of $1.00 or more for a minimum of ten consecutive trading sessions ...

Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice...

China XD Plastics Company Limited Receives Nasdaq Delisting Letter and Announces Intended Appeal Harbin, China, Sept. 10, 2021 (GLOBE NEWSWIRE) -- China XD Plastics Company Limited (Nasdaq: CXDC, the “Company”) today announced that it received a letter (the “Letter”) from the Listing...

Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price Requirement Ritter Shares Will Continue to Trade on the Nasdaq Capital Market LOS ANGELES, July 11, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the...